Literature DB >> 6274463

Dissimilar effects on body temperature in the cat produced by guanosine 3',5'-monophosphate, acetylcholine and bacterial endotoxin.

M J Dascombe, A S Milton.   

Abstract

1 Guanosine 3',5'-monophosphate (cyclic GMP) and N2-2'-O-dibutyryl guanosine 3',5'-monophosphate (db cyclic GMP) have been injected into the third cerebral ventricle (i.c.v.) of the unanaesthetized cat and the effects of rectal temperature and on behavioural and autonomic activities observed and compared with those of acetylcholine and physostigmine. 2 Acetylcholine (100 nmol) and physostigmine (100 nmol) injected together i.c.v. produced a rise in body temperature in cats at an environmental temperature of 20-24 degrees C, which was abolished by pretreatment i.c.v. with atropine (200 nmol). 3 Cyclic GMP and db cyclic GMP (10--1250 nmol) had no effect on body temperature in cats at an environmental temperature of 20--24 degrees C but produced hypothermia (1250 nmol) in cats at an environmental temperature of 9--11 degrees C. 4 The O-somatic antigen of Shigella dysenteriae (20 microgram/kg i.v.) produced fever in cats which was not potentiated by caffeine (25 mg/kg i.p.). Levels of endogenous cyclic GMP in c.s.f. taken from the cisterna magna during fever induced by bacterial endotoxin in the presence or absence of paracetamol (50 mg/kg i.p.) and/or caffeine were similar to values for afebrile cats. 5 It is concluded that exogenous cyclic GMP and db cyclic GMP can inhibit central events mediating autonomic and behavioural thermoregulation stimulated in cats by exposure to cold environments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274463      PMCID: PMC2071721          DOI: 10.1111/j.1476-5381.1981.tb09985.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  The international pyrogen reference preparation.

Authors:  J H HUMPHREY; D R BANGHAM
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

2.  Regional cyclic GMP content in incubated tissue slices of rat brain.

Authors:  G C Palmer; C R Duszynski
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

3.  Permeation of dibutyryl cAMP into HeLa cells and its convesion to monobutyryl cAMP.

Authors:  E Kaukel; H Hilz
Journal:  Biochem Biophys Res Commun       Date:  1972-01-31       Impact factor: 3.575

4.  Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain.

Authors:  J F Kuo; T P Lee; P L Reyes; K G Walton; T E Donnelly; P Greengard
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

5.  The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellum.

Authors:  J A Ferrendelli; A L Steiner; D B McDougal; D M Kipnis
Journal:  Biochem Biophys Res Commun       Date:  1970-11-25       Impact factor: 3.575

6.  Hydrolysis of cyclic guanosine and adenosine 3',5'-monophosphates by rat and bovine tissues.

Authors:  J A Beavo; J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

7.  Rose of cyclic AMP in hormone actions.

Authors:  R W Butcher
Journal:  N Engl J Med       Date:  1968-12-19       Impact factor: 91.245

8.  Studies on adenosine 3',5'-phosphate in rabbit cerebral cortex.

Authors:  S Kakiuchi; T W Rall
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

9.  Cyclic adenosine monophosphate in brain areas: microwave irradiation as a means of tissue fixation.

Authors:  M J Schmidt; D E Schmidt; G A Robison
Journal:  Science       Date:  1971-09-17       Impact factor: 47.728

10.  Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus.

Authors:  R D Myers; T L Yaksh
Journal:  J Physiol       Date:  1969-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.